Top

Elderly AML: A randomised Phase III study comparing conventional chemotherapy to low dose total body irradiation-based conditioning and hematopoietic stem cell transplantation from related and unrelated donors as consolidation therapy for older patients with AML in 1st complete remission

Study number:

2007-003514-34

Type of transplant:

Short title:

HSCT vs CT in Elderly AML

Study status:

Recruiting Patients

Deadline for data collection:

Study design:

Randomised, controlled, open, multicentre, phase III trial

Primary objective:

Efficacy of allogeneic related or unrelated heamtopoietic cell transplantation (HCT) after reduced intensityconditioning as a consolidation treatment for elderly patietns with AML in complete remission

Key inclusion criteria:

>=60, <=75 years old

Country:

Australia

Austria

Belgium

France

Germany

Netherlands

Switzerland

Principal investigator:

Dietger Niederwieser

Principal investigator email:

EBMT Study coordinator:

Ruzena Uddin

http://clinicaltrials.gov/ct2/show/NCT00766779